Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Medical management and pharmacology updateOnline only articleDermatomyositis: a contemporary review for oral health care providers⁎
Section snippets
Epidemiology
DM shows a bimodal age distribution, with children under 18 years of age and adults in their late 40s to early 60s most affected.9 DM affects females more than males, and juvenile DM (JDM) is defined by onset before 18 years of age. Information about the incidence and prevalence of DM is limited because of the rarity of the disease and its inconsistent diagnostic criteria. Earlier studies estimated an incidence ranging from 2 to 10 new cases per million persons,4, 10 and a recent
Etiology and Pathogenesis
The exact cause of DM is unknown, but it is considered a complement-mediated microangiopathy6, 12, 13 in which the specific target of immunoreaction is intramuscular capillaries. It has been hypothesized that the activation of complement components is followed by deposition of the C5b–C9 membranolytic attack complex on intramuscular capillaries, which leads to perivascular inflammation, loss of capillaries, muscle ischemia, and perifascicular muscle fiber atrophy.6, 13 However, because neither
Clinical Features
A characteristic feature of DM is skin rash mainly on the face, which precedes, accompanies, or follows progressive proximal muscle weakness. The presence of skin change has been used by many clinicians to distinguish DM from polymyositis (PM).18 However, skin lesions can be transient, atypical, or completely missing (adermatopathic DM). Similarly, the characteristic proximal symmetric muscle weakness may not be noticeable until late in the course of the disease or even completely absent
Diagnosis
Diagnostic criteria and classification of DM have been evolving since the first diagnosed case in 1875.3 An early but influential classification and set of diagnostic criteria were proposed by Bohan and Peter in 1975 (Table I),36 based mainly on their clinical experience with IIM. Most recently, a classification based on more objective diagnostic criteria, prediction of disease course, and responsiveness to therapy has been proposed (Table II). DM without muscle involvement has been fully
Medical Management and Treatment
There is no cure for DM. The goal of treatment is to manage the symptoms, improve functions, and further prevent disability. Because of the complexity of the disease, a multidisciplinary team approach and patient education are particularly important.19, 46
Prognosis
Most patients respond to early treatment. However, when cardiac or pulmonary organs are involved, patients may be refractory to therapy. Other indicators of poor prognosis include delay in diagnosis, older age, fever, dysphagia, and the association with malignancy.19 The overall 5-year survival rate is approximately 80%.9, 53 However, it is only 69% in patients with dysphagia54 and 10% in patients with cancer.55 The most common causes of death are respiratory failure in association with
Orofacial Manifestations
Along with its characteristic facial and/or scalp skin rashes, as previously described in this article, a variety of oral manifestations have been reported,57, 58, 59 sometimes as initial manifestations of DM.60, 61 However, the prevalence of oral involvement in DM is unknown. Most available information comes from single case reports or small case series, and some early case reports did not clearly separate DM from PM. The case reports we summarize below represent the best knowledge available (
Dental Considerations
Oral health providers play an important role in the early detection of DM through careful observation of patients' signs and symptoms. Identifying oral and maxillofacial cancer and dysphagia is particularly important because these conditions affect the outcome of patients with DM. During the health history review, the following questions are recommended to assess dysphagia.75, 77
Does food get stuck in your throat?
Do you have to swallow repeatedly to get rid of food?
Do you cough during meals?
Do
Conclusions
Although DM is a rare disease, its association with cancer, dysphagia, and orofacial manifestations has great relevance for oral health care providers. It is important to recognize and understand this complex disease because providers may be able to identify initial signs and symptoms in patients who are as yet undiagnosed with DM. Coordination of care with physicians is essential for successful dental management and improvement of quality of life for DM patients. Oral health care providers are
Acknowledgment
This review is dedicated to Dr. S. Miles Standish, an oral pathologist who specialized in muscle disorders.
References (88)
- et al.
Polymyositis and dermatomyositis
Lancet
(2003) - et al.
Dermatomyositis
Clin Dermatol
(2006) - et al.
Inflammatory myopathies
Baillieres Clin Rheumatol
(1995) Idiopathic inflammatory myopathies
J Neuroimmunol
(2011)- et al.
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
Lancet
(2001) - et al.
Genetic and environmental risk factors for idiopathic inflammatory myopathies
Rheum Dis Clin North Am
(2002) Inflammatory muscle diseases: a critical review on pathogenesis and therapies
Curr Opin Pharmacol
(2010)- et al.
Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies
Neuromuscul Disord
(1999) Dermatomyositis
Lancet
(2000)- et al.
The oral and facial manifestations of dermatomyositis with calcinosisReport of a case
Oral Surg Oral Med Oral Pathol
(1973)
A hoarse voice
Lancet
Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases
J Am Acad Dermatol
Amyopathic dermatomyositis (dermatomyositis siné myositis)Presentation of six new cases and review of the literature
J Am Acad Dermatol
Observations on the classification of the inflammatory myopathies
Presse Med
The treatment and prognosis of dermatomyositis: an updated review
J Am Acad Dermatol
Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients
Mayo Clin Proc
Oral lesions as an initial manifestation of dermatomyositis with occult malignancy
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
Paraneoplastic syndromes in patients with primary oral cancers: a systematic review
Br J Oral Maxillofac Surg
Tongue carcinoma in a young patient with dermatomyositis: a case report and review of the literature
J Oral Maxillofac Surg
Oropharyngeal dysphagia in dermatomyosites: case report and literature review
Braz J Otorhinolaryngol
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies
J Am Acad Dermatol
Pathogenesis and therapies of immune-mediated myopathies
Autoimmun Rev
Inflammatory myopathies: narrowing the differential diagnosis
Cleve Clin J Med
Review: an update on inflammatory and autoimmune myopathies
Neuropathol Appl Neurobiol
Elevated cancer incidence in patients with dermatomyositis: a population based study
J Rheumatol
Clinical characteristics and outcomes of juvenile and adult dermatomyositis
J Korean Med Sci
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
Ann Neurol
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis
Nat Rev Neurol
Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies
Acta Neuropathol
Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis
Arthritis Rheum
Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case–control study
Arthritis Care Res (Hoboken)
Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis
Ann N Y Acad Sci
Dermatomyositis
Am Fam Physician
Oral Epstein–Barr virus-related B-cell lymphoma causing persistent paraneoplastic dermatomyositis after nasopharyngeal and cutaneous carcinomas
Leuk Lymphoma
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children
J Rheumatol
Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases
Medicine (Baltimore)
Juvenile dermatomyositis with Sjögren's syndrome
Clin Rheumatol
Connective tissue disorders and the mouth
Dent Update
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
Arthritis Res Ther
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study
Br J Cancer
Malignancy is associated with dermatomyositis but not polymyositis in northern New England, USA
J Rheumatol
Risk of cancer in patients with dermatomyositis or polymyositisA population-based study
N Engl J Med
Dermatomyositis and malignancy: a retrospective study of 115 cases
Eur Rev Med Pharmacol Sci
Nasopharyngeal carcinoma with dermatomyositisAnalysis of 12 cases
Arch Otolaryngol Head Neck Surg
Cited by (14)
What rheumatologists should know about orofacial manifestationsof autoimmune rheumatic diseases
2016, Revista Brasileira de ReumatologiaAcquired neurocutaneous disorders
2015, Handbook of Clinical NeurologyCitation Excerpt :Gastrointestinal symptoms such as ulceration, hemorrhage, or perforation secondary to intestinal vasculopathy, particularly in children, has decreased after the use of immunosuppressive therapy (Feldman et al., 2008). Less frequently, oral manifestations including mucosal ulcers, white patches, and gingival telangiectasias can occur (Tanaka and Geist, 2012). Periungual and capillary nail bed changes are present in > 90% of juvenile dermatomyositis cases (Feldman et al., 2008).
Oral lichen planus in a dermatomyositis patient that resolved after intravenous immunoglobulin therapy
2014, Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyCitation Excerpt :In addition, muscle biopsy, electromyography, magnetic resonance imaging, and ultrasound are helpful. However, the results are not always consistent.1 This complex diagnostic process can explain why our patient underwent 5 years of investigation and was treated erroneously with courses of steroid therapy before he was finally diagnosed with DM by his rheumatologist.
Dermatomyositis: What the oral healthcare provider must know
2021, Journal of Oral Medicine and Oral SurgeryPatient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use
2020, Journal of Managed Care and Specialty Pharmacy